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a  b  s  t  r  a  c  t
Introduction: Osteoarthritis (OA) affects the articular cartilage and subchondral bone, com-
promising the joint as a whole. The knee joint is characterized as one of the main sites
of  involvement of OA and the most signiﬁcant risk factors for developing the disease are
aging, overweight and female gender. OA is considered one of the most frequent causes of
disability, which may affect the quality of life of the patients, favoring the onset of mental
disorders.
Objective: To investigate whether anxiety and depression symptoms are more  signiﬁcant in
women with OA, when compared with women without this diagnosis, and to what extent
this rheumatic disease affects the quality of life of these patients.
Methods: The study included 75 women, mean age 67 years; 40 were diagnosed with knee
OA and 35 without this diagnosis. The following instruments were used: State-Trait Anxiety
Inventory (STAI), Beck Depression Inventory (BDI) and SF-36, a quality of life questionnaire.
Results: Women with knee OA have higher rates of depression and anxiety when compared
to  controls; in addition, they have a lower quality of life.
Conclusion: We  believe that the treatment of patients with OA should consider the combina-
tion  of pharmacotherapy, psychotherapy, counseling and family support, in order to achievea  better quality of life.
© 2015 Elsevier Editora Ltda. All rights reserved.
 Study conducted at the Department of Biosciences, Universidade Federal de São Paulo (Unifesp), Santos, SP, Brazil.
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E-mail: newstein@hotmail.com (R.C.B. da Silva).
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Investigac¸ão da  ansiedade,  depressão  e  qualidade  de  vida  em  pacientes







r  e  s  u  m  o
Introduc¸ão: A osteoartrite (OA), artrose ou osteoartrose acomete a cartilagem hialina e o osso
subcondral e compromete a articulac¸ão como um todo. A articulac¸ão do joelho caracteriza-
se  como um dos principais sítios de acometimento da OA. O envelhecimento, o sobrepeso e
o  gênero (prevalência em mulheres) são os fatores de risco mais signiﬁcativos para o desen-
volvimento da doenc¸a. A OA é considerada uma das mais frequentes causas de incapacidade
laborativa e pode afetar a qualidade de vida de seus portadores e favorecer a emergência de
transtornos mentais.
Objetivo: Avaliar se os sintomas de ansiedade e depressão são mais expressivos em mulheres
com  OA quando comparados com mulheres sem tal diagnóstico e o quanto essa doenc¸a
reumática compromete a qualidade de vida desses pacientes.
Métodos: Participaram deste estudo 75 mulheres, com média de 67 anos, 40 com diagnóstico
de  OA no joelho e 35 sem. Foram usados os seguintes instrumentos: Inventário de Ansiedade
Trac¸o  e Estado, Inventário de Depressão de Beck e SF-36, questionário de qualidade de vida.
Resultados: Mulheres portadoras de OA no joelho têm níveis maiores de depressão e
ansiedade, além de apresentar qualidade de vida inferior em comparac¸ão com o grupo sem
a  doenc¸a.
Conclusão: Acreditamos que o tratamento aos portadores de OA deveria considerar a
combinac¸ão  de farmacoterapia, psicoterapia, orientac¸ão e apoio por parte dos parentes e/ou
pessoas próximas para que o paciente possa atingir melhor qualidade de vida.




























steoarthritis (OA) is the most common form of arthritis.1
t can be deﬁned as a syndrome that constitutes the ﬁnal
ommon pathway of biochemical, metabolic and physiolog-
cal changes that occur, simultaneously, in articular cartilage
causing gradual loss), subchondral bone (sclerosis), synovial
issue (inﬂammation), ligaments, joint capsule and muscles
urrounding the affected joint. There is also active bony
rowth at the joint margins.2 In the early stages of OA, chon-
rocytes, synovial cells and osteoblasts make an attempt to
epair the lesions produced in the cartilage and subchondral
one.3
The knee joint is characterized as one of the main sites of
nvolvement of OA, being present in about 6% of adults above
0 years.2 The prevalence increases to 10% in people over 60
ears of age.4 OA occurs predominantly in women after the age
f 40 in the period of menopause and in the presence of over-
eight, causing limitations and adversely affecting the quality
f life of this population.1,2
Rheumatic diseases are characterized mainly by their
hronic and disabling impairment, causing physical damage
hat limits the patient’s functional ability, directly interfering
ith his/her daily activities. In this context, OA emerges as one
f the most frequent causes of labor incapacity and, therefore,
t is critical to evaluate the psychological impacts that such a
isease may cause, as well as the quality of life of women with
his diagnosis.5Anxiety and depressive disorders can affect patients with
 diagnosis of OA, as the chronic pain caused by the disease
ncreases the risk of emergence of these commorbidities.4Elderly patients with chronic medical illnesses have shown
an increased risk of non-adherence to medical recommenda-
tions, as well as the mortality rate associated with depressive
symptoms.6
The anxiety disorder is more  common in patients with
chronic diseases, being related to the limitations experienced
by elderly patients.7,8 Considering OA as a chronic debilitat-
ing disease, it is reasonable to assume that it can be a major
stressor, favoring the emergence of this disorder. Anxiety,
characterized by an uncomfortable emotional state, manifests
itself accompanied by a series of cognitive, emotional, behav-
ioral and physiological changes. These changes often include
increased motor tension, autonomic hyperactivity, poor con-
centration, distractibility, increased vigilance and attention,
fear of losing control and of being unable to cope with the
imposed situation, escape and avoidance behaviors, nervous-
ness and increased irritability.9
Depression is a psychiatric disorder whose prevalence is
estimated at around 3–5% of the general population.7 The
most typical features of depression are: prominence of feelings
of sadness or emptiness, loss of ability to experience pleasure
in general activities and reduced interest in the environment.
Depression may be associated with fatigue and excessive
tiredness, as well as with psychomotor changes.6
Considering the impact of variables of emotional order in
the worsening of OA symptoms, this study sought to evaluate
whether the symptoms of anxiety and depression are more
signiﬁcant in women with this disease compared with women
without such a diagnosis. Additionally, the impact of OA in
the quality of life of patients was investigated, since the pain
and their implications prove to be important components for
understanding the quality of life of patients.10
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Table 2 – Performance in State-Trait Anxiety Inventory
(STAI) and Beck Depression Inventory.
Group STAI-T STAI-S BDI
With osteoarthritis
Mean 46.85 40.38 17.95
Standard deviation 13.62 10.21 12.70
Without osteoarthritis
Mean 37.65 35.06 9.15
Standard deviation 10.15 10.01 6.80
Descriptive level 0.001 0.027 0.001
STAI, State-Trait Anxiety Inventory; STAI-S, anxiety-state; STAI-T,
Descriptive means of age of groups with and without knee
osteoarthritis.
Methods
This is a cross-sectional, quantitative study. The study was
approved by the Research Ethics Committee of the Universi-
dade Federal de São Paulo (protocol 10894/2012).
Sample
The study included 75 women aged 50–72 years. Of this total,
40 women had a diagnosis of knee OA according to the Amer-
ican College of Rheumatology criteria,11 and 35 were healthy,
asymptomatic subjects, matched by gender and age. The
mean age of the group with OA was 68 years, while the mean
age in the group without OA was 65 years (Table 1). OA patients
were seen at an outpatient clinic of a university in the city of
Santos/SP. They were selected through a survey conducted by
the local medical team, coordinated by a rheumatologist. The
patients were being treated with NSAIDs and physiotherapy
for at least 1 year and at most for 2 years. The 35 women of the
control group attended to the Universidade Aberta da Terceira
Idade – UnATI, campus Santos, UNIFESP.
Instruments
The instruments used in data collection were:
State-Trait  Anxiety  Inventory  (STAI)12
The STAI comprises two scales, each consisting of 20 items,
assessing state (STAI-S) and trait (STAI-T) levels of anxiety
respectively. It is a Likert scale-type instrument, with scores
ranging from 1 (almost never) to 4 (almost always) for STAI-T,
and from 1 (not at all) to 4 (very much) for STAI-S.
Beck  Depression  Inventory13
This is a self-reported scale which contains 21 items, each
with four alternatives, with scores ascribed of 0, 1, 2 or
3. BDI items relate to cognitive-affective symptoms and
somatic/performance sensations.
Medical  outcomes  study  36-item  Short-Form  Health  Survey
(SF-36)14This instrument consists of 36 items that assess the quality of
life over eight sections, ranging from 0 to 100, where 0 = worst
and 100 = best, for each domain, namely: (1) physical func-
tioning (10 items); (2) role limitations due to physical healthanxiety-trait; BDI, Beck Depression Inventory.
(four items); (3) bodily pain (two items); (4) general health
status (ﬁve items); (5) vitality (four items); (6) social role func-
tioning (two items); (7) role limitations due to emotional
problems (three items); (8) mental health (ﬁve items).
Procedures
Data collection was performed at an ofﬁce in the outpatient
clinic or in another place deﬁned by the participant in agree-
ment with the investigator. The instruments were applied
individually, in a single session, lasting on average 30 min.
Analysis
A descriptive analysis was performed in order to study the
behavior of groups with and without OA, for each variable
of interest: State Trait Anxiety Inventory (STAI), Beck Depres-
sion Inventory (BDI) and Medical Outcomes Study 36-item
short-Form Health Survey (SF-36). Student’s t-test for unre-
lated samples was used to compare the two groups, regarding
these variables. Differences were considered signiﬁcant when
p ≤ 0.05.
Results
In Table 2 one can see that the patients in the group with
OA have higher rates in all variables studied. It is worth not-
ing that STAI considers as more  anxious those people whose
scores are higher on the questionnaire. On the other hand, BDI
scores between 0–9 are considered as no depression, 10–18
as mild depression, 19–29 as moderate depression, 30–63 as
severe depression.14
In Table 3, one can see that patients with OA had a signif-
icantly lower score in all domains examined by SF-36, when
compared with the scores of the control group.
Discussion
The aim of this study was to evaluate whether the symp-
toms of anxiety and depression are more  signiﬁcant in women
with OA compared to women without such a diagnosis, and in
which grade this rheumatic disease affects the quality of life
of these patients.
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Table 3 – Performance in the Medical Outcomes Study 36-item Short-Form Health Survey.
Domains With osteoarthritis Without osteoarthritis Descriptive level
Mean SD Mean SD
Physical functioning 44.25 25.53 78.53 21.20 0.001
Role limitations due to physical health 38.75 41.97 80.88 30.81 0.001
Pain 38.45 26.50 75.76 20.41 0.001
General health status 56.53 28.09 75.38 20.87 0.001
Vitality 52.13 27.31 66.91 20.82 0.010
Social role functioning 58.75 29.03 78.68 19.35 0.001
Role limitations due to emotional problems 52.50 43.29 80.39 32.94 0.002









































Depression in the elderly may emerge as a consequence
f general medical illnesses, especially those, such as OA,
hat cause prolonged suffering, leading the patient to physi-
al disability and loss of autonomy.15 In this study, BDI results
emonstrate that the impact of depression is important, since
epressed individuals are more  likely to report chronic pain,
r pain of greater intensity. This fact can be a complicating
actor in the process of treatment adherence, and may still
ncrease the perception of pain.16 The depressive disorder,
hen associated with physical illness, can cause the emer-
ence of anxiety symptoms.8 In this context, the results of
his study corroborate this ﬁnding.
In addition to depression and anxiety, pain and its impli-
ations on the physical and mental state of patients with
A appear to be important components, affecting decisively
he quality of life of these patients. The results of this study
ndicate a signiﬁcant worsening in the domains of SF-36
nstrument. This trend manifested itself both in the areas
ost directly related to physical health (bodily pain, physical
unctioning, role limitations due to physical health, vitality
nd general health state) and in those domains related to
ocial aspects and psychological health (role limitations due
o emotional problems and mental health).
In domains related to physical health, it was found that
he group with OA had signiﬁcantly higher levels of body pain
ompared to the control group, negatively affecting the qual-
ty of life. Regarding the domain physical functioning, which
efers to the ability of an individual to live independently in
is/her community, a decrease was observed in the group with
A. A study indicative of the quality of life in patients with
hronic rheumatic diseases5 showed that OA is characterized
y being particularly debilitating, causing physical damage
hat affects the functional ability of the patient. The results
f this study also corroborate such claims. Findings of a more
ecent study15 also show that patients with chronic pain and
ith depression exhibit a high degree of physical disability –
 ﬁnding which was also evidenced in this study. The results
bserved in the domain role limitations due to physical health
ndicated a score twice higher in the group with OA, compared
o the control group.
The domain vitality was evaluated from the responses of
he volunteers, about how long they felt exhausted, fatigued
nd with energy and vigor to carry out activities. The group
ith OA reported feeling more  fatigue and tiredness and lowerenergy and vigor to carry out activities, demonstrating a loss
in this domain. The same instrument also assessed social
aspects, based on questions about how and for how long the
physical health inﬂuenced the development of social activi-
ties.
Pain and difﬁculty in daily life activities, physical disability
and restriction of mobility and social integration generated by
disabilities can increase anxiety and discouragement,17 inten-
sifying the effects of OA and leading to a worsening of the
patient’s perception regarding his/her mental health.
It is interesting to note that the result of an inferential
analysis of comparison between the two groups (with and
without OA) showed signiﬁcant differences for all variables
investigated in this study, encompassing physical, social and
emotional dimensions. The exception was made to the vari-
able “age”, in which the difference between the two groups
was not signiﬁcant. This ﬁnding was due to the fact that the
minimum age of 50 was chosen for the composition of the
samples. The results revealed that the group with OA showed
declines in all other variables, when compared to the control
group.
Conclusion
Together, the results observed in this study showed that symp-
toms of anxiety and depression were more  signiﬁcant in
women with OA compared to women without such a diagno-
sis, emphasizing the negative impact that this disease causes
in the psychic domain and quality of life of the patients. In
this context, it is believed that the treatment of patients with
OA should consider a number of approaches, involving the
combination of pharmacotherapy, psychotherapy, counseling
and family support, so that these patients can achieve a bet-
ter quality of life. Therefore, it would be critical to involve a
support network, including professionals from different areas
such as physicians, psychologists, occupational therapists and
social workers.Conﬂicts  of  interest
The authors declare no conﬂicts of interest.
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